(R)-2-(4-Hydroxyphenoxy)propanoic acid, 95.0%, 500g

1-Boc-3-Ethynylpiperidine, 95.0%, 1g

5-ethoxy-1H-1,3-benzodiazol-2-amine, 95.0%, 250mg

4-METHYL-1H-1,2,3-TRIAZOLE, 95%, 1g

2-Chlorolepidine>98.0%(GC)5g

5-Bromothiazole-2-carboxylic acid, 95.0%, 250mg

1H-Thieno[3,2-d]pyrimidine-2,4-dione, 95.0%, 100g

KIRENOL, 98%, 5mg

4-Bromo-N-(5-fluoro-2-nitrophenyl)benzenesulfonamide, 97%, 250mg

2-Buténal, min.98%, pour la synthèse, 250 ml, emballage en verre

3-Bromo-4-ethylpyridine, 95.0%, 250mg

(2S,3aS,7aS)-1-(tert-Butoxycarbonyl)octahydro-1H-indole-2-carboxylic acid, 95.0%, 10g

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-6-dihydropyridine-1(2H)-carboxylate, 98.0%, 25g